These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14577594)

  • 1. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin.
    Abdollahi M; Chan TS; Subrahmanyam V; O'Brien PJ
    Mol Cell Biochem; 2003 Oct; 252(1-2):205-11. PubMed ID: 14577594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Van Tine BA; Azizeh BY; Trivedi D; Phelps JR; Houslay MD; Johnson DG; Hruby VJ
    Endocrinology; 1996 Aug; 137(8):3316-22. PubMed ID: 8754757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.
    Tsafriri A; Chun SY; Zhang R; Hsueh AJ; Conti M
    Dev Biol; 1996 Sep; 178(2):393-402. PubMed ID: 8812137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucagon on glycogenolysis and gluconeogenesis are region-specific in periportal and perivenous hepatocytes.
    Ikezawa Y; Yamatani K; Ogawa A; Ohnuma H; Igarashi M; Daimon M; Manaka H; Sasaki H
    J Lab Clin Med; 1998 Dec; 132(6):547-55. PubMed ID: 9851746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
    Whalen MM; Crews JD
    Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cod liver oil ameliorates sodium nitrite-induced insulin resistance and degradation of rat hepatic glycogen through inhibition of cAMP/PKA pathway.
    Al-Gayyar MM; Alyoussef A; Hamdan AM; Abbas A; Darweish MM; El-Hawwary AA
    Life Sci; 2015 Jan; 120():13-21. PubMed ID: 25447450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.
    Zurbonsen K; Michel A; Vittet D; Bonnet PA; Chevillard C
    Biochem Pharmacol; 1997 Apr; 53(8):1141-7. PubMed ID: 9175719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of the intestinal peptide PHI on glycogenolysis and gluconeogenesis in isolated rat hepatocytes.
    Felíu JE; Marco J
    Biochem J; 1983 Sep; 214(3):999-1002. PubMed ID: 6312969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gluconeogenesis in rabbit liver. IV. The effects of glucagon, epinephrine, alpha- and beta-adrenergic agents on gluconeogenesis and pyruvate kinase in hepatocytes given dihydroxyacetone or fructose.
    Yorek MA; Rufo GA; Blair JB; Ray PD
    Biochim Biophys Acta; 1981 Jul; 675(3-4):309-15. PubMed ID: 6268188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of somatostatin on glucagon-stimulated glycogenolysis and gluconeogenesis in hepatocytes cultured in vitro.
    Rosa J; Rosa J; Fister V
    Acta Physiol Scand; 1992 Oct; 146(2):205-11. PubMed ID: 1359734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
    Kochetkova M; Burns FM; Souness JE
    Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic response of teleost hepatocytes to glucagon-like peptide and glucagon.
    Mommsen TP; Moon TW
    J Endocrinol; 1990 Jul; 126(1):109-18. PubMed ID: 2166124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.